![](/img/cover-not-exists.png)
A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients
Derfuss, T., Curtin, F., Guebelin, C., Bridel, C., Rasenack, M., Matthey, A., Du Pasquier, R., Schluep, M., Desmeules, J., Lang, A. B., Perron, H., Faucard, R., Porchet, H., Hartung, H.-P., Kappos, L.Volume:
21
Language:
english
Journal:
Multiple Sclerosis Journal
DOI:
10.1177/1352458514554052
Date:
June, 2015
File:
PDF, 1.10 MB
english, 2015